Karen

If you could get substantially longer, thicker, darker lashes, but the process risked permanently darkening your irises, would you still do it?

Earlier this month, the FDA approved the very first drug for use promoting eyelash growth, according to Allergan, the company that makes the drug.

Latisse, available by prescription early in 2009, contains the same active ingredient in the glaucoma drug Lumigan, which is also made by Allergan.

Eyelash growth has long been a known side effect of Lumigan, so Allergan figured they’d take advantage of the side effect, repurposing Lumigan as Latisse.

While Lumigan is an eyedrop, Latisse gets dabbed along the lash line on the upper eyelids, where it goes to work promoting longer, thicker, darker lashes.

How well does it work?

Allergan claims that Latisse users can expect longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks, and one clinical study involving 278 adult patients (here’s the product information PDF) backs up the claim.
[Continue reading…]

Hey, ladies! I’m writing this post from my phone at the airport. I was supposed to leave Oahu last night on a red eye, but there was a massive power outage all over the island. The airport was shut down and all the outbound flights were cancelled. I managed to get on a flight this morning, though, so it’s all good. Because of these unexpected events, I won’t be able to blog until I get home later on tonight, but I’ll check in again after landing.

I just wanted to pop by to wish you a good day. Have a lovely Saturday, and I’ll talk to you soon.

Your friendly neighborhood beauty addict,

Karen

Sephora’s running a huge blowout sale with select holiday items marked down up to 75% off (and free shipping)! There’s lots of good pickings, too, including products from Vincent Longo, Too Faced and Pop Beauty.

If you decide to get a little something for yourself, I promise I won’t tell Santa. 🙂

Your friendly neighborhood beauty addict,

Karen